CRBP
#3854
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
5.2 7 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.04%
Variazione Mensile
-33.54%
Variazione di 6 mesi
-48.08%
Variazione Annuale
-68.25%
Chiusura Precedente
5.3 8
Open
5.3 5
Minimo
5.1 1
Massimo
5.4 0
Financials
2024
Quarterly report, Q1 FY2024
Corbus Pharmaceuticals Holdings, Inc. quarterly report, Q1 FY2024
10-Q
Current report, 20 Mar 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 20 March 2024
8-K
Current report, 12 Mar 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 12 March 2024
8-K
Current report, 02 Feb 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 02 February 2024
8-K
Current report, 30 Jan 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 30 January 2024
8-K
Current report, 30 Jan 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 30 January 2024
8-K
Current report, 29 Jan 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 29 January 2024
8-K
Current report, 26 Jan 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 26 January 2024
8-K
Current report, 08 Jan 2024
Corbus Pharmaceuticals Holdings, Inc. current report, 08 January 2024
8-K
2023
Annual report, FY2023
Corbus Pharmaceuticals Holdings, Inc. annual report, FY2023
10-K